Featured
Again, Bitcoin dips, millions of dollars lost
The world’s most popular cryptocurrency has fallen below $59,000, wiping out millions of dollars of traders and investors.
Wednesday’s crash came as long-term Bitcoin holders sold at a high price in order to make significant profits.
Days ago, the digital currency traded around $67,000, a record high.
The price drop has also caused a run on other cryptocurrencies, including Ethereum, Binance Coin, Cardano, Solana and Ripple which have also seen their value fall.
The price of Ethereum has slumped nearly six percent to under $4 over the past 24 hours, according to the latest data from CoinDesk.
Cardano’s value has plummeted almost nine percent in the same period to less than $2, while Solana has fallen 8.05 percent to $190.
The cryptocurrency markets have been whipsawing, especially following news of big holders like Elon Musk tweeting, and the market reacting.
Earlier this year, experts warned cryptocurrencies remain concentrated among a small number of holders.
At the end of last year (2020), the 10,000 biggest Bitcoin holders accounted for more than a quarter (27 percent) of the total 18.6 million coins in circulation.
The latest dip may allow more buyers itching to get in on the ride—for the next rally.
Cryptocurrency prices have surged this year, with Bitcoin alone jumping almost 400 percent in value over the past 12 months.
-
Football1 week agoXabi Alonso targets Arda Guler as Chelsea prepare €100m transfer bid
-
Football1 week agoFIFA confirms Jay-Jay Okocha holds World Cup record
-
Business7 days agoDangote cuts petrol, diesel prices again to boost affordability, economic activity
-
Aviation1 week agoInside Airport Luggage Theft: Experts warn of rising insider syndicates
-
Politics1 week agoAmuwo Odofin: Umeadi emerges winner of NDC Reps Primary
-
Featured1 week agoPSG edge Arsenal on penalties to retain Champions League crown
-
Football1 week agoChampions League Final: Talking points ahead of Arsenal vs. PSG match
-
Health4 days agoSenate hearing set to review research on COVID-19 vaccines, cancer concerns

